258 related articles for article (PubMed ID: 27481772)
1. α-Synuclein: Experimental Pathology.
Hasegawa M; Nonaka T; Masuda-Suzukake M
Cold Spring Harb Perspect Med; 2016 Sep; 6(9):. PubMed ID: 27481772
[TBL] [Abstract][Full Text] [Related]
2. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
3. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
4. Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.
Rey NL; George S; Brundin P
Neuropathol Appl Neurobiol; 2016 Feb; 42(1):51-76. PubMed ID: 26666838
[TBL] [Abstract][Full Text] [Related]
5. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
[TBL] [Abstract][Full Text] [Related]
6. Electron Microscopic Analysis of α-Synuclein Fibrils.
Tarutani A; Hasegawa M
Methods Mol Biol; 2021; 2322():17-25. PubMed ID: 34043188
[TBL] [Abstract][Full Text] [Related]
7. Propagation of pathological α-synuclein in marmoset brain.
Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
[TBL] [Abstract][Full Text] [Related]
8. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
9. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology underlying clinical variability in patients with synucleinopathies.
Halliday GM; Holton JL; Revesz T; Dickson DW
Acta Neuropathol; 2011 Aug; 122(2):187-204. PubMed ID: 21720849
[TBL] [Abstract][Full Text] [Related]
11. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
Peelaerts W; Bousset L; Baekelandt V; Melki R
Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213
[TBL] [Abstract][Full Text] [Related]
12. Is Multiple System Atrophy a Prion-like Disorder?
Jellinger KA; Wenning GK; Stefanova N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
[TBL] [Abstract][Full Text] [Related]
14. α-Synucleinopathy phenotypes.
McCann H; Stevens CH; Cartwright H; Halliday GM
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S62-7. PubMed ID: 24262191
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles.
Meade RM; Fairlie DP; Mason JM
Mol Neurodegener; 2019 Jul; 14(1):29. PubMed ID: 31331359
[TBL] [Abstract][Full Text] [Related]
16. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain.
Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P
Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772
[TBL] [Abstract][Full Text] [Related]
18. Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril.
Kim C; Lv G; Lee JS; Jung BC; Masuda-Suzukake M; Hong CS; Valera E; Lee HJ; Paik SR; Hasegawa M; Masliah E; Eliezer D; Lee SJ
Sci Rep; 2016 Aug; 6():30891. PubMed ID: 27488222
[TBL] [Abstract][Full Text] [Related]
19. Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy.
Lövestam S; Schweighauser M; Matsubara T; Murayama S; Tomita T; Ando T; Hasegawa K; Yoshida M; Tarutani A; Hasegawa M; Goedert M; Scheres SHW
FEBS Open Bio; 2021 Apr; 11(4):999-1013. PubMed ID: 33548114
[TBL] [Abstract][Full Text] [Related]
20. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]